XAVFLI O‘SMALAR (RAK) KASALLIKLARI: EPIDEMIOLOGIK TURLARI, ETIO-PATOGENETIK OMILLARI, KLINIK ASORATLARI VA ZAMONAVIY INTEGRATIV DAVOLASH HAMDA PROFILAKTIKA STRATEGIYALARI

Authors

  • Jamolxonova Dildora Umidjon qizi University of Business and Science Davolash ishi yo‘nalishi 25-26 guruh talabasi Author
  • Ibragimov Farrux Otabek o‘g‘li University of Business and Science Davolash ishi yo‘nalishi 25-26 guruh talabasi Author
  • Ahmadjonova Ezoza Anvarjon qizi University of Business and Science Davolash ishi yo‘nalishi 25-26 guruh talabasi Author
  • Isaqjonov Javohir Xasanali o'g'li University of Business and Science Davolash ishi yo‘nalishi 25-26 guruh talabasi Author
  • Ergashboyeva Maftuna Baxtiyor qizi University of Business and Science Davolash ishi yo‘nalishi 25-26 guruh talabasi Author
  • Abdujalulova Kumushoy Ikromjon qizi University of Business and Science Davolash ishi yo‘nalishi 25-27 guruh talabasi Author

Keywords:

xavfli o‘smalar, karsinogenez, metastaz, mutatsiya, kimyoterapiya, maqsadli (target) terapiya, birlamchi profilaktika, skrining

Abstract

Ushbu maqolada xavfli o‘smalar (rak) kasalliklarining zamonaviy onkologiyadagi o‘rni, epidemiologik turlari, hujayra proliferatsiyasi va karsinogenezning patofiziologik mexanizmlari tahlil qilingan. Onkologik patologiyalarni keltirib chiqaruvchi endogen (irsiy, gormonal) va ekzogen (kimyoviy, fizik, virusli) xavf omillarining roli yoritilgan. Tadqiqot davomida kasallikning og‘ir tizimli asoratlari (kaxeksiya, metastazlanish) hamda zamonaviy integrativ davolash usullari (jarrohlik, kimyoterapiya, maqsadli va immunoterapiya) hamda skrining-profilaktika tizimining klinik ahamiyati asoslab berilgan.

References

1. Sung, H., Ferlay, J., Siegel, R. L., et al. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209-249.

2. Schirrmacher, V. (2019). From signposts of cancer to integrative targeted and immunotherapy: a review. Journal of Cancer Research and Clinical Oncology, 145(2), 271-285.

3. Siegel, R. L., Miller, K. D., & Fuchs, H. E. (2022). Cancer statistics, 2022. CA: A Cancer Journal for Clinicians, 72(1), 7-33.

4. Navruzov, S. N., & Alieva, D. A. (2023). O‘zbekistonda xavfli o‘smalar epidemiologiyasi va erta skrining tizimining dolzarb muammolari. O‘zbekiston Onkologiyasi Jurnali, 1(18), 12-19.

5. Xodjaev, A. T. (2024). Tarqalgan xavfli o‘smalarni davolashda zamonaviy target va immunoterapiya vositalarining klinik samaradorligi. Tibbiyotda Yangi Kun, 2(48), 104-111.

Downloads

Published

2026-06-08

Issue

Vol. 3 No. 4 (2026): MODERN EDUCATIONAL SYSTEM AND INNOVATIVE TEACHING SOLUTIONS

Section

Articles